Symptoms
NSW pharmacies to offer COVID-19 vaccine to under-40s
About 450 community pharmacies in New South Wales will be able to administer the AstraZeneca COVID-19 vaccine to patients under 40 years of age from next week, the NSW Premier announced today.
Intranasal naloxone spray could reduce opioid-related deaths
Naloxone has long been used by emergency responders in cases of known or suspected opioid overdose. It has been accessible over-the-counter (OTC) in an...
How will post-lockdown restrictions impact pharmacists?
After more than 100 days in lockdown, New South Wales pharmacists reflect on the challenges of the past few months and what lies ahead.
Acute care opioid prescribing overhauled
A new standard of care will help to prevent long-term reliance on opioid analgesics used for acute pain.
Over 30% increase in asthma deaths in one year
The significant rise in Australian asthma deaths is cause for immediate and widespread concern. Here’s what experts say needs to change.
Government pulls the plug on replica Ozempic
After much media scrutiny, the federal Department of Health and Aged Care has announced a ban on compounded GLP-1RAs.
